Key result
NP-Y rs16147 CT-genotype is linked to lower WHR and higher leptin in women versus homozygotes.
Why the study?
The role of the functional SNP rs16147 in the NP-Y promoter gene in relation to serum leptin levels and body fat distribution remains inconclusive.
Is the NP-Y rs16147 polymorphism associated with serum leptin levels and body fat distribution in Caucasian subjects?
Case-Control (n=1,097)
Yes
Is the NP-Y rs16147 polymorphism associated with serum leptin levels and body fat distribution in Caucasian subjects?
The NP-Y rs16147 polymorphism is associated with body fat distribution and serum leptin levels in women, suggesting a sex-specific genetic influence on obesity-related traits.
CT genotype linked to lower WHR and higher leptin in women only; leaves open sex-specific NPY effects on adiposity pending replication.
OBJECTIVE: The neuropeptide-Y (NP-Y) gene is a strong candidate gene in the pathophysiology of obesity-linked behavior, and several single-nucleotide polymorphisms of NP-Y have already been linked to body weight and appetite. However, the results from current studies remain inconclusive. The aim of the present study was to test whether a certain functional genetic variant (SNP rs16147) in the NP-Y promoter gene is associated with serum leptin levels and body fat distribution. METHOD: We genotyped and measured the serum leptin levels of the NP-Y rs16147 polymorphism in 1,097 Caucasian subjects in the context of a population-based, case-control multicenter study. We measured weight, height and waist circumference, from which we then calculated BMI and waist-to-hip ratio (WHR). RESULTS: We found the CT-genotype of the SNP rs16147 to be significantly associated with lower WHRs and higher serum leptin levels in women, compared to homozygote gene carriers. No association between rs16147, WHR and serum leptin levels was found in men. CONCLUSION: Our results provide evidence that the functionally relevant SNP in the NP-Y promoter gene affects body fat distribution and serum leptin levels in women, pointing towards possible behavioral effects of NPY in obesity.
No takes yet. Share an insight, caveat, or question.
Mutschler et al. (2013) conducted a case-control in Obesity (n=1,097). NP-Y rs16147 polymorphism (CT-genotype) vs. Homozygote gene carriers was evaluated on Serum leptin levels and waist-to-hip ratio (WHR). The CT-genotype of the NP-Y rs16147 polymorphism was significantly associated with lower waist-to-hip ratios and higher serum leptin levels in women compared to homozygote carriers.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: